Evidence map›Paper›PMID 33237976›Full record

Trial reportPloS one2020

Human papillomavirus genotype distribution and factors associated among female sex workers in West Africa.

Fatoumata Korika Tounkara, Ibrahima Téguété, Fernand A Guédou, Ella Goma-Matsétsé, Amadou Koné, Luc Béhanzin, Sidy Traoré, Marlène Aza-Gnandji, Bintou Keita, Julie Guenoun and 2 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Genetic and Epigenetic Variations of HPV52 in Cervical Precancer.International journal of molecular sciences · 2021
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Fatoumata Korika TounkaraDépartement de Médecine Sociale et Préventive, Université Laval, Québec, QC, Canada.
Ibrahima TéguétéCentre Hospitalier Universitaire Gabriel Toure, Bamako, Mali.
Fernand A GuédouAxe Santé des Populations et Pratiques Optimales en Santé, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada.
Ella Goma-MatsétséCentre de Santé de Cotonou-1, Dispensaire des Infections Sexuellement Transmissibles (DIST), Cotonou, Benin.
Amadou KonéCentre Universitaire de Recherche Clinique (UCRC), Bamako, Mali.
Luc BéhanzinCentre de Santé de Cotonou-1, Dispensaire des Infections Sexuellement Transmissibles (DIST), Cotonou, Benin.
Sidy TraoréCentre Hospitalier Universitaire Gabriel Toure, Bamako, Mali.
Marlène Aza-GnandjiCentre de Santé de Cotonou-1, Dispensaire des Infections Sexuellement Transmissibles (DIST), Cotonou, Benin.
Bintou KeitaAssociation de Recherche de Communication et d'Accompagnement à Domicile de personnes Vivant avec le VIH (ARCAD-SIDA), Bamako, Mali.
Julie GuenounDépartement de Microbiologie et Infectiologie, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
François CoutléeDépartement de Microbiologie et Infectiologie, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
Michel AlaryDépartement de Médecine Sociale et Préventive, Université Laval, Québec, QC, Canada.ORCID 0000-0002-0246-4429
Centre Hospitalier de l’Université de Montréal · CAThe Quebec Population Health Research Network · CAUniversity of Bamako · MLAssociation de Recherche de Communication et d’Accompagnement à Domicile de personnes Vivant avec le VIH · MLInstitut National de Santé Publique du Québec · CAUniversité des Sciences, des Techniques et des Technologies de Bamako · ML

Funding

CIHR FDN-143218
6 · The paper itself

Abstract

objectivesThis study aimed to: (1) Estimate HPV prevalence and genotype distribution among female sex workers (FSWs) in Mali and Benin as well as the prevalence of multiple HPV type infections in this group, and (2) Identify potential risk factors associated with high-risk (HR) HPV infections.

methodsWe analyzed baseline data of 665 FSWs aged ≥ 18 years recruited during a prospective cohort of cervical cancer screening in Cotonou (Benin) and Bamako (Mali) from 2017 to 2018. The Linear Array HPV genotyping test was used to identify HPV genotypes. Descriptive statistics and multivariate log-binomial regression were used. Adjusted prevalence ratios (APR) with 95% confidence intervals (95%CI) were estimated to identify risk factors associated with HR-HPV infections.

resultsHPV data were available for 659 FSWs (Benin: 309; Mali: 350). The mean age was 35.0 years (± 10.7) in Benin and 26.8 years (± 7.6) in Mali. The overall HPV prevalence rates were 95.5% in Benin and 81.4% in Mali. About 87.7% and 63.4% of FSWs harbored ≥ 2 HPV types in Benin and Mali, respectively. The top three prevalent HR-HPV among FSWs in Benin were: HPV58 (37.5%), HPV16 (36.6%) and HPV52 (28.8%). Corresponding patterns in Mali were HPV16 (15.7%), HPV51 (14.3%) and HPV52 (12.9%). In Benin, the main factors associated with HR-HPV were vaginal douching (APR = 1.17; 95%CI:1.02-1.34) and gonococcal infection (APR = 1.16; 95%CI:1.04-1.28), while in Mali they were sex work duration ≤ 1 year (APR = 1.35; 95%CI:1.10-1.65) and HIV infection (APR = 1.26; 95%CI: 1.06-1.51).

conclusionOur study found a very high prevalence of HPV infection as well as high frequency of multiple HPV type infections in FSWs in two countries in West Africa. These findings suggest the necessity to emphasize cervical cancer prevention in this high-risk group.

Indexed as

GenotypePapillomavirus InfectionsSex WorkersUterine Cervical NeoplasmsAdolescentAdultAlphapapillomavirusBeninFemaleHumansMaliPrevalenceProspective StudiesRisk Factors

Identifiers

PMID33237976
PMCPMC7688172
OpenAlexW3107174808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.